101 related articles for article (PubMed ID: 3281588)
1. Distinction between glycoprotein IIIa and the 100-kDa membrane protein (aggregin) mediating ADP-induced platelet activation.
Colman RW; Figures WR; Wu QX; Chung SY; Morinelli TA; Tuszynski GP; Colman RF; Niewiarowski S
Arch Biochem Biophys; 1988 Apr; 262(1):298-306. PubMed ID: 3281588
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
[TBL] [Abstract][Full Text] [Related]
3. Separation of the 100-kDa membrane protein mediating ADP-induced platelet shape change and activation from glycoprotein IIIa.
Colman RW; Figures WR; Wu QX; Chung SY; Morinelli TA; Tuszynski GP; Colman RF; Niewiarowski S
Trans Assoc Am Physicians; 1986; 99():39-45. PubMed ID: 3603928
[TBL] [Abstract][Full Text] [Related]
4. Aggregin: a platelet ADP receptor that mediates activation.
Colman RW
FASEB J; 1990 Mar; 4(5):1425-35. PubMed ID: 2407587
[TBL] [Abstract][Full Text] [Related]
5. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
7. Immunoaffinity method to identify aggregin, a putative ADP-receptor in human blood platelets.
Puri RN; Colman RW
Arch Biochem Biophys; 1997 Nov; 347(2):263-70. PubMed ID: 9367534
[TBL] [Abstract][Full Text] [Related]
8. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa.
Kornecki E; Tuszynski GP; Niewiarowski S
J Biol Chem; 1983 Aug; 258(15):9349-56. PubMed ID: 6308003
[TBL] [Abstract][Full Text] [Related]
10. A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptor.
Puri RN; Colman RW
Anal Biochem; 1996 Sep; 240(2):251-61. PubMed ID: 8811919
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ADP-induced platelet responses by covalent modification of aggregin, a putative ADP receptor, by 8-(4-bromo-2,3-dioxobutylthio)ADP.
Puri RN; Kumar A; Chen H; Colman RF; Colman RW
J Biol Chem; 1995 Oct; 270(41):24482-8. PubMed ID: 7592664
[TBL] [Abstract][Full Text] [Related]
12. Comparison of platelet fibrinogen receptors on intact and proteolytically-treated platelets by use of an anti-glycoprotein IIIa monoclonal antibody (MA 123).
Kornecki E; Lee H; Merlin F; Hershock D; Tuszynski GP; Niewiarowski S
Thromb Res; 1984 Apr; 34(1):35-49. PubMed ID: 6328693
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets.
Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS
Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345
[TBL] [Abstract][Full Text] [Related]
15. Assembly and GPIIIa content of cytoskeletal core in platelets agglutinated with bovine von Willebrand factor.
Puszkin EG; Mauss EA; Zucker MB
Blood; 1990 Oct; 76(8):1572-9. PubMed ID: 2119831
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an antibody raised against reduced glycoprotein IIIa of human platelets.
Eckardt AJ; Cook JJ; Niewiarowski S
Thromb Res; 1991 Apr; 62(1-2):43-54. PubMed ID: 1853305
[TBL] [Abstract][Full Text] [Related]
17. Activation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolytic cleavage at the carboxyterminus of the membrane glycoprotein IIb heavy chain.
Pidard D; Frelinger AL; Bouillot C; Nurden AT
Eur J Biochem; 1991 Sep; 200(2):437-47. PubMed ID: 1889410
[TBL] [Abstract][Full Text] [Related]
18. Plasmin-induced platelet aggregation is accompanied by cleavage of aggregin and indirectly mediated by calpain.
Puri RN; Zhou FX; Colman RF; Colman RW
Am J Physiol; 1990 Dec; 259(6 Pt 1):C862-8. PubMed ID: 2148055
[TBL] [Abstract][Full Text] [Related]
19. Interaction of nucleotide affinity analog 5'-p-fluorosulfonylbenzoyladenosine with platelet ADP receptor: aggregin.
Figures WR; Scearce LM; Colman RF; Colman RW
Methods Enzymol; 1992; 215():143-55. PubMed ID: 1435320
[No Abstract] [Full Text] [Related]
20. Tryptic digestion of human GPIIIa. Isolation and biochemical characterization of the 23 kDa N-terminal glycopeptide carrying the antigenic determinant for a monoclonal antibody (P37) which inhibits platelet aggregation.
Calvete JJ; Rivas G; Maruri M; Alvarez MV; McGregor JL; Hew CL; Gonzalez-Rodriguez J
Biochem J; 1988 Mar; 250(3):697-704. PubMed ID: 2455507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
